Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
life sciences
national blog main
san diego blog main
san diego top stories
3
×
biotech
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alder biopharmaceuticals
alnylam pharmaceuticals
amgen
andrew fire
bial
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
craig mello
david rind
detroit blog main
detroit top stories
drug development
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
What
fda
3
×
gets
3
×
drug
nod
add
afternoon
alnylam
alnylam’s
amgen
approval
approved
called
candidates
carbidopa
class
combination
control
daily
developed
disease
experience
head
history
landmark
levodopa
making
medication
medicine
medicines
migraine
neurocrine
new
ok
onpattro
pain
parkinson’s
patients
patisiran
pharmaceuticals
pill
Language
unset
Current search:
fda
×
gets
×
" san diego top stories "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
